Assessing heterogeneity of treatment effect in multiple sclerosis trials

Multiple sclerosis (MS) is heterogeneous with respect to outcomes, and evaluating possible heterogeneity of treatment effect (HTE) is of high interest. HTE is non-random variation in the magnitude of a treatment effect on a clinical outcome across levels of a covariate (i.e. a patient attribute or s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sormani, Maria Pia, Chataway, Jeremy, Kent, David M, Marrie, Ruth Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Meeting Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413777/
https://www.ncbi.nlm.nih.gov/pubmed/37555493
http://dx.doi.org/10.1177/13524585231189673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413777/
https://www.ncbi.nlm.nih.gov/pubmed/37555493
http://dx.doi.org/10.1177/13524585231189673

Ejemplares similares